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Purpose:  Hepatic  steatosis  is  an  increasingly  frequent  disease  with  potentially  severe




steatosis  monitoring.  This  study  aimed  at  evaluating  steatosis  quantiﬁcation  via  a  standard  1.5  T
MRI machine  in  a  murine  model.
Materials  and  methods:  Eleven  groups  of  two  rats  received  a  choline  methionine  deﬁcient  diet.
MRI was  performed  at  days  0,  2,  4,  5,  6,  7  and  8,  and  weeks  2,  3,  4  and  5.  A  phased  array
surface coil  system  was  used  to  acquire  a  GE  T1  in-  and  out-of-phase  multi-echo  sequence,
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with  neither  cardiac  nor  respiratory  synchronization.  Steatosis  was  calculated  with  the  3-echoes
method.  Histological  quantiﬁcations  were  performed  both  by  optical  analysis  (percentage  of
fatty hepatocytes)  and  by  automated  measurement  of  the  area  of  steatosis  (AOS).  The  reference
was total  intrahepatic  triglycerides  (TIT).  Protocol  was  approved  by  the  ethic  committee.
Results: Steatosis  without  inﬂammation,  increasing  with  diet  duration,  was  obtained.  MRI  pro-
vided better  agreement  (intraclass  correlation  coefﬁcient)  with  TIT  (0.889,  p  <  0.001)  than  did
AOS (0.629,  p  =  0.001)  or  optical  analysis  (0.280,  p  =  0.098).  MRI  permitted  closer  monitoring  of
TIT over  time  than  did  AOS  or  optical  analysis.  By  multivariate  analysis,  MRI  was  an  indepen-
dent predictor  of  TIT  on  ﬁrst  step  and  ALT  on  second  step.  A  model  combining  these  2  variables
provided  excellent  agreement  with  TIT  (0.953,  p  <  0.001)  and  permitted  excellent  monitoring
of steatosis  over  time.
Conclusion:  MRI  is  reliable,  easy,  fast  and  superior  to  histological  techniques  for  the  assessment
of hepatic  steatosis  in  a  murine  model.





































































Eonalcoholic  fatty  liver  disease  (NAFLD)  is  increasingly  fre-
uent  among  adults  and  children.  Its  prevalence  reaches
0—30%  in  the  general  population  and  75—100%  in  obese
opulations  [1—3].  Adipose  tissue  is  commonly  associated
ith  insulin  resistance  and  it  is  now  widely  accepted  that
atty  liver  is  an  element  of  metabolic  syndrome  (MS)  [4,5]
bdominal  fat  is  also  a  risk  factor  for  a  subset  of  cancers  [6].
urthermore,  NAFLD  and  insulin  resistance  in  hepatocytes
hare  molecular  characteristics  [7—10].  NAFLD  encompasses
 wide  spectrum  of  liver  lesions,  ranging  from  bland  steatosis
o  nonalcoholic  steatohepatitis  (NASH),  ﬁbrosis,  and  ﬁnally
irrhosis  with  its  potentially  fatal  complications:  hepatocel-
ular  carcinoma,  liver  failure,  variceal  bleeding,  and  renal
ailure.  Steatosis  is  present  across  the  entire  spectrum  of
esions  observed  in  NAFLD.  Studies  have  previously  shown
hat  liver  steatosis  amount  is  associated  with  NASH,  ﬁbro-
is,  and  metabolic  syndrome  components  in  NAFLD  [11].
hus,  early  management  of  steatosis  is  crucial  and  new  ther-
pies  are  indeed  in  the  pipeline.  To  evaluate  these  new
reatments  in  pre-clinical  studies,  researchers  need  murine
nduced  liver  steatosis  models  and  a  fast,  easy  and  efﬁcient
teatosis  quantiﬁcation  technique  without  mouse  sacriﬁce
o  permit  monitoring.
Several  animal  models  have  been  developed  to  obtain
teatosis  [12].  They  work  by  increasing  lipids  import  or
ynthesis  [13,14],  affecting  methionine  metabolism  [15],
ncreasing  lipid  uptake  [16—19]  and  ﬁnally  by  decreasing
xport  of  VLDL  particles  and,  to  a  lesser  extend,  beta-
xidation  with  a  choline  methionine  deﬁcient  diet  (CMDD)
20,21],  which  is  known  as  a  NASH  model  in  rats.  However,  a
rotocol  to  obtain  graded  steatosis  has  never  been  published
nd  obtaining  pure  steatosis  without  inﬂammation  has  not
een  described  with  this  model.
Steatosis  is  usually  quantiﬁed  by  standard  semi-
uantitative  histological  grading  on  liver  biopsy  with  visual
nalysis,  evaluating  the  percentage  of  hepatocytes  contain-
ng  lipid  vacuoles.  We  have  developed  another  histological
ethod,  called  area  of  steatosis  (AOS),  for  the  automated
nd  more  reliable  measurement  of  lipid  vacuole  surface  on
iver  specimens  [11].  However,  obtaining  liver  histology  sam-
les  from  rats  requires  their  sacriﬁce  and  therefore  repeated
S
b
Seasurements  for  monitoring  are  not  possible.  Moreover,
istology  suffers  from  sampling  variability  [22].  To  resolve
hese  difﬁculties,  non-invasive  methods  for  hepatic  steato-
is  quantiﬁcation  have  been  developed.  In  humans  studies,
otwithstanding  the  utility  of  ultrasound,  MRI  is  considered
o  be  the  most  pertinent  method  [23,24].  Several  tech-
iques  are  applicable  [25]  including  the  ‘‘3-echoes’’  method
chieved  through  an  ‘‘in-  and  out-of-phase’’  T1  sequence
26,27].  Most  of  the  studies  that  validated  MRI  as  a  steatosis
uantiﬁcation  tool  used  spectroscopy  or  histological  scores
s  a  reference.  To  our  knowledge,  none  used  total  intrahep-
tic  triglycerides  (TIT),  although  it  is  expected  to  be  the
est  reference  because  TIT  are  indeed  what  all  the  tech-
iques  aims  to  quantify.  Finally,  to  broaden  the  utility  of
RI  as  a steatosis  quantiﬁcation  tool,  it  must  be  feasible
n  a  standard  machine,  with  neither  cardiac  nor  respiratory
ynchronization.
The  aim  of  this  study  was  to  evaluate  hepatic  steatosis
uantiﬁcation  using  a  standard  1.5  T  MRI  device,  in  com-
arison  to  classical  optical  evaluation  of  steatosis  by  a
athologist  and  to  AOS,  using  TIT  as  reference.
ethods and materials
nimals
he  protocols  employed  in  our  laboratory  were  approved
y  the  French  Ministry  for  Higher  Education  and  Research
n  conformity  with  European  legislation  for  research  involv-
ng  animals  under  the  reference  number  CEEA.2011.1  of  the
thics  Committee.
Twenty-two  7  to  8-week-old  Sprague  Dawley  rats  (Ani-
alerie  hospitalo-universitaire,  Angers,  France)  weighting
pproximately  280  g  were  used.
xperimental model and designteatosis  was  induced  by  a  speciﬁc  nutritional  regimen
ased  on  the  choline  methionine  deﬁcient  diet  (CMDD;
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in  a  polycarbonate  cage  with  a  12-hour  light/12-hour  dark
cycle  and  controlled  temperature  (22  ±  2 ◦C)  and  humidity
(50  ±  10%).  They  had  ad  libitum  access  to  food  and  tap
water.  The  population  was  divided  into  eleven  experimental
groups  of  2  rats.  Ten  groups  were  subjected  to  the  CMDD
during  respectively  2,  4,  5,  6,  7  and  8  days  and  2,  3,  4  and
5  weeks  in  order  to  obtain  increasing  levels  of  steatosis.
The  remaining  group  was  used  as  a  control.
MRI  was  performed  the  evening  of  the  last  diet  day,  after
a  12-hour  fasting  period.  On  the  morning  following  the  MRI,
the  animals  were  anesthetized  with  a  mixture  of  O2 and
isoﬂurane  2.5%  for  an  intracardiac  blood  sample,  then  sac-
riﬁced  by  asphyxiation  in  a  CO2-saturated  atmosphere.  The
livers  were  removed,  weighed  and  sampled  for  histological
assessment.  Additional  samples  were  snap  frozen  in  liquid
nitrogen  for  later  measurement  of  TIT.
MRI evaluation
1.5  T  MRI  (General  Electrics  Excite,  Milwaukee,  IL)  was
carried  out  using  a  phased  array  knee  coil,  with  neither
cardiac  nor  respiratory  synchronization.  The  examinations
were  performed  under  general  anesthesia  (O2 and  isoﬂu-
rane  2.5%  applied  with  a  handmade  gas  mask).  There  was  no
contention  and  no  respiratory  assistance.  Rats  are  in  ventral
decubitus.A  GE  T1  ‘‘in-  and  out-of-phase’’  multi-echo
sequence  was  performed  covering  the  whole  liver,
with  the  following  parameters:  ﬂip  angle  =  40◦, time





Figure 1. MRI steatosis quantiﬁcation with the 3-echoes method in a r
in ventral decubitus. Largest sharp middle liver slice, the same region o
vessels except for the inferior vena cava, was used to measure the mean
6.7 (b) and 8.8 ms (c). Values are expressed in arbitrary unit.eatosis  amount  917
f  256*256,  thickness  =  4  mm,  spacing  =  4.5  mm,  number  of
lices  =  3,  acquisition  time  =  32  s.  No  cardiac  or  respiratory
ating  was  needed.
Steatosis  quantiﬁcation  was  performed  on  a  medical
orkstation  (Synapse,  Fuji,  Tokyo)  by  a trained  practitioner.
Two  operators  realized  the  measures  separately.  The
argest  sharp  middle  liver  slice  was  selected  and  a  free-
and  region  of  interest  (ROI)  covering  the  maximum  of  the
iver  surface  was  drawn  regardless  of  vessels  except  for
he  inferior  vena  cava  (Fig.  1).  The  same  ROI  was  used
o  measure  the  mean  signal  value  on  the  2nd,  3rd  and
th  echo.  Then  steatosis  was  calculated  with  the  3-echoes
ethod  [29]:
100  ×  [mean  (2nd  +  4th)  −  3rd]/[2  ×  mean  (2nd  +  4th)].
All  steatosis  quantiﬁcation  results  are  expressed  as  per-
entages.
iochemical analysis
lucose  concentrations  in  blood  serum  were  measured
sing  a  glucometer,  and  total  cholesterol,  HDL  and  LDL
holesterol,  aspartate  aminotransferase  (AST),  alanine
minotransferase  (ALT),  and  -glutamyltransferase  (GGT)
ere  measured  using  enzymatic  assay  kits  on  a  Hitachi  917
utomatic  analyzer  (Roche).  Liver  triglycerides  were  deter-
ined  using  the  method  described  by  Xu  et  al.  [30].  Brieﬂy,
00  mg  of  liver  tissue  was  homogenized  in  1  ml  of  ethanol
hen  centrifuged  at  15,000  x  g  for  10  min.  TG  were  mea-
ured  with  a  kit  (Sigma  —  Aldrich,  St.  Louis,  MO).  Results  are
xpressed  as  percentages.
at undergoing a choline methionine deﬁcient diet (CMDD). Rats are
f interest covering the maximum of the liver surface regardless of
 signal value on the 2nd, 3rd and 4th echo at respectively 4.6 (a),



















































Table  1  Correlations  between  methods  for  quantiﬁca-
tion  of  liver  steatosis.
R  p  ICC  p
TIT  vs  optical  analysis  0.753  <  0.001  0.280  0.098
TIT  vs  AOS  0.889  <  0.001  0.629  0.001
TIT  vs  MRI  0.897  <  0.001  0.889  <  0.001
MRI  vs  optical  analysis  0.739  <  0.001  0.344  0.054
MRI  vs  AOS  0.891  <  0.001  0.797  <  0.001
Optical  analysis  vs  AOS 0.892  <  0.001  0.605  0.001
R: Spearman correlation coefﬁcient; ICC: intra-class correlation




































iver  samples  were  ﬁxed  in  4%  buffered  formal  saline
nd  embedded  in  parafﬁn  wax.  Five-m thick  sections
ere  stained  with  hematoxylin-eosin-saffron  (HES)  and  0.1%
icrosirius  red  solution  and  used  for  both  optical  and  image
nalysis.
ptical analysis
teatosis  was  calculated  as  the  percentage  of  hepatocytes
ontaining  lipid  vacuoles.  Microvesicular  or  macrovesicular
teatosis  was  noted.  Inﬂammation  was  graded  as  follows:  0:
o  inﬂammation,  1:  mild,  2:  moderate  or  severe.
rea of Steatosis
rea  of  steatosis  was  measured  as  previously  described
31,32].  Brieﬂy,  for  image  acquisition,  we  used  an  Aperio
igital  slide  scanner  (Scanscope  CS  System,  Aperio  Technolo-
ies,  Vista  CA  92081,  USA)  image  processor  that  provided
igh  quality  30,000  ×  30,000  pixel  images  at  a  resolution
f  0.5  m/pixel  (magniﬁcation  ×  20).  Binary  images  (white
or  steatosis  and  black  for  the  remaining  liver  tissues)  were
btained  via  an  automatic  thresholding  technique  using  an
lgorithm  developed  in  our  laboratory.  The  entire  specimen
rea  was  analyzed.  AOS  (%)  was  calculated  as  the  ratio:  area
f  steatosis  vesicles/complete  liver  surface.
tatistics
orrelations  were  calculated  using  Spearman’s  coefﬁcient
R),  and  agreement  using  intra-class  correlation  coefﬁcient
ICC).  A  value  of  p  <  0.05  was  considered  as  statistically  sig-
iﬁcant.  Statistical  evaluations  were  performed  using  SPSS
oftware  v18.0  (IBM,  Armonk,  NY,  USA).  A  Bland  Altman  anal-
sis  was  performed  between  MRI,  AOS,  Histology  and  the
IT.
esults
on-invasive quantiﬁcation of steatosis
ll  the  MRI  acquisition  provided  at  least  one  slice  with  visu-
ly  good  quality  and  sharpness.  The  mean  signal  to  noise
atio  was  25,7.
TIT,  our  reference  for  liver  steatosis,  was  measured  at
.6%  in  the  control  rats.  Only  one  rat  (#21),  which  received
he  CMDD  during  5  weeks,  presented  steatohepatitis  (grade
).  MRI  quantiﬁcation  was  possible  for  all  rats.  The  agree-
ent  between  the  two  observers  was  excellent:  ICC  =  0.998
0.996—0.999].
We  ﬁrst  pooled  all  the  results  obtained  at  the  various  time
oints  to  evaluate  the  correlations  between  the  different
ethods  for  steatosis  evaluation.  MRI  and  AOS  correlated
etter  with  TIT  than  did  optical  analysis,  with  respective  R
f  0.897,  0.889  and  0.753  (all  p  <  0.001)  (Table  1  and  Fig.  3).
owever,  agreement  with  TIT  was  better  for  MRI  (0.889, <  0.001)  compared  to  AOS  (0.629,  p  =  0.001)  or  optical  anal-
sis  (0.280,  p  =  0.098).  By  stepwise  multiple  linear  regression
ith  TIT  as  the  dependent  variable  and  MRI,  AOS  and  optical




rn  independent  predictor  of  TIT.  Taken  together,  the  results
uggested  that  steatosis  amount,  as  reﬂected  by  TIT,  was
etter  assessed  by  MRI.
onitoring of steatosis time course
ccording  to  TIT  results,  steatosis  started  to  increase  pro-
ressively  at  day  7  (11%)  of  the  CMDD  diet  to  reach  33.4%
fter  5  weeks  (Fig.  2).  The  accuracy  of  optical  analysis  for
he  evaluation  of  steatosis  progression  was  poor  (Fig.  2):
teatosis  quantiﬁcation  went  directly  from  0%  during  the
rst  week  to  90%  at  day  7,  then  continued  giving  high
alues  between  80  and  95%.  This  analysis  showed  macro
acuoles  (except  for  rat  #4  in  the  2-day  group,  which  had
icrovacuoles)  and  thus  a high  optical  steatosis  value  (80%)
hereas  TIT  remained  at  a  normal  level  (9.3%).  In  compari-
on,  AOS  permitted  closer  monitoring  of  steatosis  (Fig.  2)  but
he  method  underestimated  steatosis  when  TIT  was  <  20%
nd  overestimated  it  when  TIT  was  above  this  threshold
Figs.  2  and  3b).
Finally,  MRI  offered  the  best  performance  for  monitoring,
ith  a  time  curve  very  close  to  TIT  (Fig.  2).  MRI  evaluated
teatosis  initially  at  8.2%  with  a  slight  increase  during  the
rst  week.  Then,  MRI  quantiﬁcation  started  to  increase  pro-
ressively  to  reach  37%  after  5  weeks  of  the  CMDD  diet.
lood markers
lood  cholesterol,  LDL  and  triglycerides  levels  were  signif-
cantly  correlated  with  TIT  with  respective  R of  −0.799,
0.771  and  −0.761  (all  p  <  0.001).  Liver  enzymes  were  also
igniﬁcantly  correlated  with  TIT,  with  respective  R  for  AST
nd  ALT  of  0.458  (p  =  0.032)  and  0.585  (p  =  0.004)  (Table  2
nd  Fig.  4).
Cholesterol,  LDL  and  triglycerides  decreased  with  diet
uration  whereas  liver  enzymes  increased  after  week  2.  No
igniﬁcant  modiﬁcation  of  HDL,  GT  or  glycemia  was  found.
By  stepwise  multiple  linear  regression  including  MRI  and
lood  markers  for  the  non-invasive  quantiﬁcation  of  steato-
is,  independent  predictors  of  TIT  were  MRI  (1st  step)  and
LT  (2nd  step).  The  regression  formula  of  the  multivariate
nalysis  was:  (0.905*MRI  result)  −  (0.019*ALT  [IU/L])  +  1.931.
teatosis  estimation  using  this  model  was  very  well  cor-
elated  with  TIT  (Fig.  5)  with  R  =  0.910  (p  <  0.001)  and
MRI  versus  histological  methods  for  time  course  monitoring  of  steatosis  amount  919
Figure 2. Steatosis quantiﬁcation results with each technique, for every rat, increasing with diet duration. The reference, total intrahep-
atic triglycerides (TIT), is represented by the solid black line and MRI the dotted line. The dotted gray line is visual optical quantiﬁcation
and the solid gray line is automated area of steatosis (AOS).
Figure 3. Correlation graphs between total intrahepatic triglycerides (TIT) and MRI ICC = 0.889; p < 0.001 (a), area of steatosis (AOS)
ICC = 0.629; p = 0.001 (b), and visual histology ICC = 0.280; p = 0.098 (c). Bland Altman analysis between MRI and TIT (d).
920  L.-M.  Leiber  et  al.
Table  2  Correlations  between  total  intrahepatic
triglycerides  and  blood  markers.
R  p
Glucose  −0.247  0.268
Cholesterol  −0.799  <  0.001
HDL  −0.067  0.766
LDL  −0.771  <  0.001
Triglycerides −0.761 <  0.001
AST  0.458  0.032
ALT 0.585  0.004
















































tigure 4. Correlation between total intrahepatic triglycerides
TIT) and ALT R = 0.585; p = 0.004.
CC  =  0.952  (p  <  0.001)  and  permitted  very  close  monitoring
f  steatosis  evolution  over  time  (Fig.  2).
iscussion
teatosis  indeed  occurs  in  over  nutrition  but  it  is  mainly
ue  to  an  imbalance  between  dietary  practices  and  today’s
ncreasingly  sedentary  lifestyle  and  has  thus  become  a  major
ealth  problem  worldwide  [33].  The  consequences  of  the
isease,  including  roles  in  insulin  resistance  and  the  possi-
le  evolution  to  steatohepatitis  and  ﬁbrosis,  are  well  known
ow,  but  the  mechanisms  behind  them  remain  incompletely
nderstood.
Murine  models  are  thus  needed  to  gain  a  better  under-
tanding  of  the  pathology  and  its  diverse  elements,  and  to
ake  therapeutic  studies  possible.
The  choline  methionine  deﬁcient  diet  (CMDD)  is  a  NASH
odel  that  results  in  high  values  of  steatosis  and  hepatitis.  In
his  study  we  demonstrated  that  CMDD  can  be  used  to  create
a
migure 5. Correlation between total intrahepatic triglycerides
TIT) and a model combining MRI + ALT (ICC = 0.953; p < 0.001).
ncreasing  degrees  of  steatosis  free  from  inﬂammation  in  a
elatively  short  period.
Via  this  gamut  of  steatosis  thus  created,  we  were  able
o  evaluate  different  steatosis  quantiﬁcation  techniques  at
ifferent  levels  of  steatosis  in  good  conditions.
The  classical  visual  evaluation  of  steatosis  measures  the
ercentage  of  hepatocytes  containing  lipid  vacuoles.  How-
ver,  vacuoles  appear  when  steatosis  starts  to  increase,  and
n  our  study,  the  result  furnished  by  the  test  leaped  directly
rom  0  to  nearly  100%.  This  ‘‘all  or  nothing’’  result,  with
o  ability  to  illustrate  progression,  is  thus  clearly  unsuited
or  the  precise  measurement  of  steatosis,  and  even  more  so
or  the  demonstration  of  small  variations  regarding  a  thera-
eutic  effect.  This  can  explain  the  variability  of  the  results
n  the  D7  group  with  histology:  as  steatosis  starts  to  raise,
ipids  vacuoles  appears  but  are  neglected  by  the  anato-
opathologist  because  there  are  too  small  until  they  reach
imultaneously  a  sufﬁcient  size.  On  the  opposite,  the  same
ifﬁculty  can  also  explain  the  variability  in  the  D2  group  as
he  rat  with  high  results  of  steatosis  had  microvacuoles  in
0%  of  hepatocytes  whereas  they  did  not  contain  much  lipids
r  represent  a  signiﬁcant  surface  with  AOS.
AOS  was  well  correlated  with  TIT  in  our  study,  and
ay  well  be  the  best  histological  technique  for  quantify-
ng  steatosis.  However  we  did  observe  that  AOS  tended  to
verestimate  steatosis.  This  observation  may  be  explained
y  the  presence  of  vacuoles  containing  more  than  just  lipids
r  by  the  modiﬁcation  of  vacuole  size  during  histological
reparation.
Finally,  among  the  different  techniques  tested  in  our
tudy,  MRI  provided  the  best  correlation  with  TIT.  Its  correla-
ion  was  furthermore  highly  statistically  signiﬁcant  despite
he  small  number  of  subjects.  MRI  also  offers  the  additional
dvantage  of  being  non-invasive.
Our  results  conﬁrmed  the  poor  reliability  of  biological
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in  principle,  be  used  in  conjunction  with  MRI,  but  it  is  our
opinion  that  any  possible  improvement  in  results  would  not
be  worth  the  price  and  complexity  of  the  test.
The  use  of  a  standard  1.5  T  MRI  obliges  a  compromise.
To  limit  T1  pollution  in  quantiﬁcation,  authors  have  rec-
ommended  using  a  small  ﬂip  angle,  usually  20◦ [34,35].
However  in  our  study,  due  to  the  small  size  of  the  rats,  we
needed  to  use  a  40◦ ﬂip  angle  to  increase  the  signal.  The  use
of  a  3  T  MRI  device  or  a  dedicated  surface  coil  would  permit
a  smaller  ﬂip  angle.
However,  our  goal  in  the  present  work  was  to  present  a
convenient  way  to  quantify  steatosis  in  important  cohorts  of
rats  with  non-speciﬁc  equipment.  In  the  technique  described
here,  examination  times  are  short,  a  standard  1.5  T  machine
is  sufﬁcient  and  there  is  no  need  for  respiratory  synchro-
nization.  We  also  assumed  several  technical  imperfections
to  avoid  dealing  with  the  multiple  chemical  proﬁles  of  fat.
Similarly,  we  did  not  test  more  precise  techniques,  such  as
the  correction  of  confounding  factors  or  synchrotron  Fourier
transform  infrared  microspectroscopy,  which  are  much  more
difﬁcult  to  implement  and  to  handle  [36,37].
Conclusion
In  conclusion,  liver  steatosis  in  rat  models  can  be  easily
and  precisely  quantiﬁed  with  a  standard  1.5  T  MRI  device.
MRI  not  only  eliminates  the  need  for  animal  sacriﬁce,  thus
enabling  monitoring,  it  also  correlates  better  with  total  liver
triglycerides  than  histological  quantiﬁcation  methods.
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